Comment on: A pooled subgroup analysis of glucarpidase treatment in 86 pediatric, adolescent, and young adult patients receiving high-dose methotrexate therapy in open-label trials

被引：0
|
作者：
Meyers, Paul A. [1 ,2 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10065 USA
来源：
PEDIATRIC BLOOD & CANCER | 2024年 / 70卷 / 11期
关键词：
D O I：
10.1002/pbc.30617
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Treatment of depressive symptoms in patients with schizophrenia: a randomized, open-label, parallel-group, flexible-dose subgroup analysis of patients treated with extended-release quetiapine fumarate or risperidone
    Kasper, Siegfried
    Montagnani, Gino
    Trespi, Graziella
    Di Fiorino, Mario
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2015, 30 (01) : 14 - 22
  • [32] High-dose versus standard-dose daunorubicin in induction therapy for young patients with de novo acute myeloid leukaemia: a meta-analysis of randomised trials
    Su, Long
    Zhu, Xiaoqing
    Gao, Sujun
    Li, Wei
    Liu, Xiaoliang
    Tan, Yehui
    JOURNAL OF CHEMOTHERAPY, 2016, 28 (02) : 123 - 128
  • [33] Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials (vol 379, pg 641, 2012)
    Johnston, C.
    Saracino, M.
    Kuntz, S.
    LANCET, 2012, 379 (9816): : 616 - 616
  • [34] TRIPLE COMBINATION THERAPY WITH VEDOLIZUMAB, ADALIMUMAB, AND METHOTREXATE IN PATIENTS WITH HIGH-RISK CROHN'S DISEASE: INTERIM ANALYSIS FROM THE OPEN-LABEL, PHASE 4 EXPLORER TRIAL
    Colombel, Jean Frederic
    Ungaro, Ryan C.
    Sands, Bruce E.
    Siegel, Corey A.
    Wolf, Douglas C.
    Valentine, John F.
    Kadali, Harisha
    Nazarey, Pradeep
    James, Alexandra
    Lasch, Karen
    Rana-Khan, Qasim
    GASTROENTEROLOGY, 2022, 162 (07) : S215 - S215
  • [35] Is one or two infusions better in the first week of low-dose ketamine treatment for medication-resistant depression? A post hoc pooled analysis of randomized placebo-controlled and open-label trials
    Chen, Mu-Hong
    Wu, Hui-Ju
    Li, Cheng-Ta
    Lin, Wei-Chen
    Tsai, Shih-Jen
    Hong, Chen-Jee
    Tu, Pei-Chi
    Bai, Ya-Mei
    Mao, Wei-Chung
    Su, Tung-Ping
    JOURNAL OF PSYCHIATRIC RESEARCH, 2021, 144 : 448 - 454
  • [36] Efficacy analysis of empirical bismuth quadruple therapy, high-dose dual therapy, and resistance gene-based triple therapy as a first-line Helicobacter pylori eradication regimen - An open-label, randomized trial
    Jiang, Xin
    Deng, Bin
    Gao, Xuefeng
    Zhang, Yun
    Li, Guangyao
    Li, Guiqing
    She, Qiang
    Ding, Yanbing
    OPEN MEDICINE, 2023, 18 (01):
  • [37] A randomized open-label parallel-group study comparing ondansetron with ondansetron plus dexamethasone in patients with metastatic breast cancer receiving high-dose epirubicin. A Hellenic Cooperative Oncology Group study
    Janinis, J
    Giannakakis, T
    Athanasiades, A
    Fountzilas, G
    Bafaloukos, D
    Kosmidis, P
    Nikolaides, K
    Pavlidis, N
    Skarlos, D
    TUMORI, 2000, 86 (01) : 37 - 41
  • [38] Improved Outcome of a Pediatric-Inspired Protocol for High-Risk Adolescent and Young Adult Acute Lymphoblastic Leukemia Patients Using Peg-Asparaginase and Escalating Dose of Methotrexate: Tolerability and Outcome
    Hanbali, Amr
    Kotb, Ahmed
    El Fakih, Riad
    Alfraih, Feras
    Ahmed, Syed Osman
    Shaheen, Marwan
    Hashmi, Shahrukh
    Alhayli, Saud
    Alahmari, Ali
    Abu Riash, Mahmoud
    Rasheed, Walid
    Alzahrani, Hazzaa
    Alsharif, Fahad
    Chaudhri, Naeem
    Almohareb, Fahad
    Aljurf, Mahmoud
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : 670 - 677
  • [39] Ultra-short course, high-dose primaquine to prevent Plasmodium vivax infection following uncomplicated pediatric malaria: A randomized, open-label, non-inferiority trial of early versus delayed treatment
    Woon, Sze-Ann
    Moore, Brioni R.
    Laman, Moses
    Tesine, Paula
    Lorry, Lina
    Kasian, Bernadine
    Yambo, Phantica
    Yadi, Gumul
    Pomat, William
    Batty, Kevin T.
    Salman, Sam
    Robinson, Leanne J.
    Davis, Timothy M. E.
    Manning, Laurens
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 130 : 189 - 195
  • [40] High-dose vitamin D supplementation for cancer-treatment-induced bone loss in 164 breast and prostate cancer patients: A pooled analysis of two randomized controlled trials (RCTs).
    Peppone, Luke Joseph
    Kleckner, Amber
    Inglis, Julia Ellen
    Reschke, Jennifer E.
    Belcher, Elizabeth
    Kleckner, Ian
    Xu, Huiwen
    Lin, Po-Ju
    Mustian, Karen Michelle
    Janelsins, Michelle Christine
    Culakova, Eva
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345